The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.
Serotonin 5-HT2 Receptor Interactions with Dopamine Function: Implications for Therapeutics in Cocaine Use Disorder
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–289 of 289
A genetic switch for long-term memory
Pittenger, C., & Kandel, E. R. (1998) · Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(97)89807-1 · Cited by 74
McGrew, L., Chang, M. S. S., & Sanders‐Bush, E. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1339 · Cited by 73
Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats.
Filip, M. (2005) · PubMed · Cited by 70
Auclair, A. L., Cathala, A., Sarrazin, F., Depoortère, R., Piazza, P. V., Newman‐Tancredi, A., & Spampinato, U. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06848.x · Cited by 69
Efferent and afferent connections of the dorsal and median raphe nuclei in the rat
Vertes, R. P., & Linley, S. B. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8561-3_3 · Cited by 68
Clark, R. N., Ashby, C. R., Dewey, S. L., Ramachandran, P. V., & Strecker, R. E. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199607)23:3<125::aid-syn1>3.0.co;2-a · Cited by 68
The Rate Hypothesis and Agonist Substitution Approaches to Cocaine Abuse Treatment
Gorelick, D. A. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60914-x · Cited by 67
Serotonin transporters upregulate with chronic cocaine use
Mash, D. C., Staley, J. K., Izenwasser, S., Basile, M. J., & Ruttenber, A. J. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00102-2 · Cited by 67
Selective Interaction of ARF1 with the Carboxy-Terminal Tail Domain of the 5-HT2A Receptor
Robertson, D. N., Johnson, M. S., Moggach, L. O., Holland, P. J., Lutz, E. M., & Mitchell, R. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1239 · Cited by 65
Manvich, D. F., Kimmel, H. L., & Howell, L. L. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.186981 · Cited by 65
Self-citationZayara, A. E., McIver, G., Valdivia, P. N., Lominac, K. D., McCreary, A. C., & Szumlinski, K. K. (2011) · Psychopharmacology · doi:10.1007/s00213-010-1996-3 · Cited by 64
Bowers, B. J., Henry, M. B., Thielen, R. J., et al. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751625.x · Cited by 63
Kittler, K., Lau, T., & Schloss, P. D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.010 · Cited by 63
Serotonin system gene polymorphisms are associated with impulsivity in a context dependent manner
Stoltenberg, S. F., Christ, C. C., & Highland, K. B. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.012 · Cited by 62
Abdallah, L. E., Bonasera, S. J., Hopf, F. W., O'Dell, L., Giorgetti, M., Jongsma, M., Carra, S., Pierucci, M., Giovanni, G. D., Esposito, E., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3905-08.2009 · Cited by 62
Goudriaan, A. E., Veltman, D. J., van den Brink, W., Dom, G., & Schmaal, L. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.04.006 · Cited by 61
Effects of Cocaine and MDMA Self-Administration on Serotonin Transporter Availability in Monkeys
Banks, M. L., Czoty, P. W., Gage, H. D., Bounds, M. C., Garg, P., Garg, S., & Nader, M. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301420 · Cited by 60
LeSage, M. G., Stafford, D. A., & Glowa, J. R. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00015-9 · Cited by 59
Monoamine Transporter Inhibitors and Substrates as Treatments for Stimulant Abuse
Howell, L. L., & Negus, S. S. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00004-4 · Cited by 58
Self-citationThe association between frontal–striatal connectivity and sensorimotor control in cocaine users
Hanlon, C. A., Wesley, M. J., Stapleton, J. R., Laurienti, P. J., & Porrino, L. J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.008 · Cited by 58
Koskinen, T., Ruotsalainen, S., & Sirviö, J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00241-0 · Cited by 58
Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine
Newton, T. F., Ling, W. W., Kalechstein, A. D., Uslaner, J. M., & Tervo, K. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00255-4 · Cited by 58
Katsidoni, V., Apazoglou, K., & Panagis, G. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1887-7 · Cited by 57
Navarra, R. L., Comery, T. A., Graf, R., Rosenzweig-Lipson, S. J., & Day, M. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.016 · Cited by 56
Schenk, S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00377-4 · Cited by 55
Kuroki, T., Meltzer, H., & Ichikawa, J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02516-2 · Cited by 55
Auclair, A. L., Blanc, G., Glowinski, J., & Tassin, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02714.x · Cited by 55
Anastasio, N. C., Stoffel, E. C., Fox, R. G., Bubar, M. J., Rice, K. C., Moeller, F. G., & Cunningham, K. A. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328345f90d · Cited by 55
Self-citationMcGrew, L., Price, R. D., Hackler, E., Chang, M. S. S., & Sanders‐Bush, E. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.252 · Cited by 54
Ciraulo, D. A., Sarid‐Segal, O., Knapp, C. M., Ciraulo, A. M., LoCastro, J. S., Bloch, D. A., Montgomery, M. A., Leiderman, D. B., & Elkashef, A. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.00985.x · Cited by 53
Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei
Vázquez, P. M., Celada, P., Cortés, R., & Artigas, F. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000349 · Cited by 53
Navailles, S., Deurwaerdère, P. D., & Spampinato, U. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.035 · Cited by 52
(2011) · Wiley eBooks · doi:10.1002/9781118023150 · Cited by 52
Pattern of distribution of serotonergic fibers to the orbitomedial and insular cortex in the rat
Linley, S. B., Hoover, W. B., & Vertes, R. P. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2012.12.006 · Cited by 51
The effects of chronic cocaine exposure on impulsivity in rats
Dandy, K. L., & Gatch, M. B. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328330ad89 · Cited by 50
Leggio, G. M., Cathala, A., Moison, D., Cunningham, K. A., Piazza, P. V., & Spampinato, U. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.10.005 · Cited by 50
Self-citationEvenden, J. L. (1998) · Psychopharmacology · doi:10.1007/s002130050773 · Cited by 50
Leggio, G. M., Cathala, A., Nény, M., Rougé‐Pont, F., Drago, F., Piazza, P. V., & Spampinato, U. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06356.x · Cited by 49
Egerton, A., Ahmad, R., Hirani, E., & Grasby, P. M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1226-4 · Cited by 49
Striatal Dopamine Release and Genetic Variation of the Serotonin 2C Receptor in Humans
Mickey, B. J., Sanford, B., Love, T., Shen, P., Hodgkinson, C. A., Stohler, C. S., Goldman, D. A., & Zubieta, J.-K. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1260-12.2012 · Cited by 49
Sertraline delays relapse in recently abstinent cocaine‐dependent patients with depressive symptoms
Oliveto, A. H., Poling, J. C., Mancino, M. J., Williams, D. K., Thostenson, J., Pruzinsky, R., Gonsai, K., Sofuoglu, M., Gonzalez, G. M., Tripathi, S. P., et al. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03552.x · Cited by 48
Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys
Glowa, J. R., Rice, K. C., Matecka, D., & Rothman, R. B. (1997) · Neuroreport · doi:10.1097/00001756-199704140-00006 · Cited by 48
Murnane, K. S., Winschel, J., Schmidt, K. T., Stewart, L. M., Rose, S. J., Cheng, K., Rice, K. C., & Howell, L. L. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1437-13.2013 · Cited by 47
Self-citationSchmitz, J. M., Mooney, M. E., Green, C. E., Lane, S. D., Steinberg, J. L., Swann, A. C., & Moeller, F. G. (2009) · Journal of Addictive Diseases · doi:10.1080/10550880903028502 · Cited by 46
Loebl, T., Angarita, G. A., Pachas, G. N., Huang, K., Lee, S. H., Nino, J., Logvineko, T., Maravić, M. C., & Evins, A. E. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0321 · Cited by 46
Blokland, A., Şık, A., & Lieben, C. K. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00004 · Cited by 46
Recovering from cocaine: Insights from clinical and preclinical investigations
Hanlon, C. A., Beveridge, T. J. R., & Porrino, L. J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.007 · Cited by 45
Anastasio, N. C., Liu, S., Maili, L., Swinford-Jackson, S. E., Lane, S. D., Fox, R. G., Hamon, S., Nielsen, D. A., Cunningham, K. A., & Moeller, F. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.131 · Cited by 45
Self-citationBruce, K. R., Steiger, H., Joober, R., Kin, N. M. K. N. Y., Israël, M., & Young, S. N. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30205 · Cited by 44
Serotonin-like immunoreactive cells and fibres in the rat ventromedial mesencephalic tegmentum
Halliday, G. M., & Törk, I. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90092-0 · Cited by 43
Hebb, M. O., & Robertson, H. A. (2000) · The Journal of Comparative Neurology · Cited by 43
Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder
Burnet, P. W. J., Smith, K., Cowen, P. J., et al. (1999) · Psychiatric Genetics · doi:10.1097/00041444-199906000-00009 · Cited by 41
Advances in Animal Models of Relapse for Addiction Research
Weiss, F. (2010) · Frontiers in neuroscience · doi:10.1201/9781420007350-c1 · Cited by 40
Qu, Y., Aluisio, L. E., Lord, B., Boggs, J. D., Hoey, K., Mazur, C., & Lovenberg, T. W. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.01.023 · Cited by 39
Garoflos, E., Stamatakis, A., Mantelas, A., Philippidis, H., & Stylianopoulou, F. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.032 · Cited by 39
Fentress, H. M., Grinde, E., Mazurkiewicz, J. E., Backstrom, J. R., Herrick‐Davis, K., & Sanders‐Bush, E. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500315 · Cited by 39
Booth, R. G., Fang, L., Huang, Y.-S., Wilczynski, A. M., & Sivendran, S. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.035 · Cited by 39
Failure of ritanserin to block cocaine cue reactivity in humans
Ehrman, R. N., Robbins, S. J., Cornish, J., Childress, A. R., & O’Brien, C. P. (1996) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01278-1 · Cited by 38
Serotonergic modulation of the discriminative-stimulus effects of cocaine in squirrel monkeys
Schama, K. F., Howell, L. L., & Byrd, L. D. (1997) · Psychopharmacology · doi:10.1007/s002130050316 · Cited by 38
Self-citationThe Prefrontal Cortex: Anatomy, Physiology and Neuropsychology of the Frontal Lobe, 3rd Edition.
Mayer, R. F. (1999) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199902000-00012 · Cited by 38
The use of drug discrimination procedures to characterize hallucinogenic drug actions.
Appel, J. B., & Cunningham, K. A. (1986) · PubMed · Cited by 38
Self-citationImpact of Serotonin (5-HT)2C Receptors On Executive Control Processes
Pennanen, L., van der Hart, M., Yu, L., & Tecott, L. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.258 · Cited by 37
From War to Classroom: PTSD and Depression in Formerly Abducted Youth in Uganda
Winkler, N., Ruf‐Leuschner, M., Ertl, V., Pfeiffer, A., Schalinski, I., Ovuga, E., Neuner, F., & Elbert, T. R. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00002 · Cited by 37
Biomarkers for the Development of New Medications for Cocaine Dependence
Bough, K. J., Amur, S., Lao, G., Hemby, S. E., Tannu, N. S., Kampman, K. M., Schmitz, J. M., Martínez, D., Merchant, K., Green, C., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.210 · Cited by 37
Cox, S. M. L., Benkelfat, C., Dagher, A., Delaney, J. S., Durand, F., Kolivakis, T., Casey, K. F., & Leyton, M. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.084178 · Cited by 37
Neurobiological Changes Mediating the Effects of Chronic Fluoxetine on Cocaine Use
Sawyer, E. K., Mun, J.-Y., Nye, J. A., Kimmel, H. L., Voll, R. J., Stehouwer, J. S., Rice, K. C., Goodman, M. M., & Howell, L. L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.29 · Cited by 36
Self-citationManvich, D. F., Kimmel, H. L., Cooper, D. A., & Howell, L. L. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.195156 · Cited by 36
Self-citationRüedi‐Bettschen, D., Rowlett, J. K., Spealman, R. D., & Platt, D. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1705-2 · Cited by 35
Risperidone diminishes cocaine-induced craving
Garza, R. I. D. L., Newton, T., & Kalechstein, A. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2010-8 · Cited by 35
López‐Giménez, J. F., Mengod, G., Palacios, J. M., & Vilaró, M. T. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00827.x · Cited by 35
Mechanisms of ERK1/2 Regulation by Seven-Transmembrane-Domain Receptors
Werry, T. D., Christopoulos, A., & Sexton, P. M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873725 · Cited by 35
Broderick, P. A., Olabisi, O. A., Rahni, D. N., & Zhou, Y. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.007 · Cited by 34
Predicting abuse potential of stimulants and other dopaminergic drugs: Overview and recommendations
Huskinson, S. L., Naylor, J. E., Rowlett, J. K., & Freeman, K. B. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.009 · Cited by 34
Abbas, A. I., & Roth, B. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711335105 · Cited by 33
Murnane, K. S., Andersen, M. L., Rice, K. C., & Howell, L. L. (2013) · Journal of Sleep Research · doi:10.1111/jsr.12045 · Cited by 32
Self-citationFilip, M., Spampinato, U., McCreary, A. C., & Przegaliński, E. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.035 · Cited by 32
Synapse distribution of olfactory interneurons in the procerebrum of the snail Helix aspersa
Ratt�, S., & Chase, R. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000214)417:3<337::aid-cne7>3.0.co;2-o · Cited by 29
Baumann, M. H., & Rothman, R. B. (1996) · Neuropharmacology · doi:10.1016/0028-3908(95)00166-2 · Cited by 28
Gould, R. W., Gage, H. D., Banks, M. L., Blaylock, B. L., Czoty, P. W., & Nader, M. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.007 · Cited by 27
Moeller, F. G., Steinberg, J. L., Lane, S. D., Kjome, K. L., Ma, L., Ferré, S., Schmitz, J. M., Green, C. E., Bandak, S. I., Renshaw, P. F., et al. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00044 · Cited by 26
Addiction Therapeutics: Obstacles and Opportunities
Skolnick, P., & Volkow, N. D. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.004 · Cited by 24
5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail
Barclay, Z., Dickson, L., Robertson, D. N., Johnson, M. S., Holland, P. J., Rosie, R., Sun, L., Fleetwood‐Walker, S., Lutz, E. M., & Mitchell, R. (2011) · Biochemical Journal · doi:10.1042/bj20101844 · Cited by 20
Herin, D. V., Bubar, M. J., Seitz, P. K., Thomas, M. L., Hillman, G. R., Tarasenko, Y. I., Wu, P., & Cunningham, K. A. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00002 · Cited by 20
Self-citationKimmel, H. L., Manvich, D. F., Blough, B. E., Negus, S. S., & Howell, L. L. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.09.007 · Cited by 20
Self-citationCarrasco, G. A., de Kar, L. D. V., Sullivan, N. R., Landry, M., García, F., Muma, N. A., & Battaglia, G. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.021 · Cited by 18
Walstab, J., Steinhagen, F., Brüss, M., Göthert, M., & Bönisch, H. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70397-8 · Cited by 14
Teuns, G., Geys, H., Geuens, S., Stinissen, P., & Meert, T. F. (2014) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2014.02.002 · Cited by 9
Drug Discovery and Development for Reward Disorders: Views from Government
McCann, D. J., Acri, J. B., & Vocci, F. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00022-9 · Cited by 1
Cornea-Hébert (1999) · doi:10.1002/(sici)1096-9861(19990628)409:2<187::aid-cne2>3.0.co;2-p
Cited by
The dopamine motive system: implications for drug and food addiction
Volkow, N. D., Wise, R. A., & Baler, R. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.130 · Cited by 939
Synaptic mechanisms underlying persistent cocaine craving
Wolf, M. E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.39 · Cited by 393
Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Self-citationImpact of cocaine abuse on HIV pathogenesis
Dash, S., Balasubramaniam, M., Villalta, F., Dash, C., & Pandhare, J. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01111 · Cited by 67
Bayassi-Jakowicka, M., Lietzau, G., Czuba, E., Steliga, A., Waśkow, M., & Kowiański, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189806 · Cited by 43
Metadata
- Authors
- Howell, L. L., & Cunningham, K. A.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 67
- Issue
- 1
- Pages
- 176-197
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2060324739
- Cited by
- 262
- References
- 289
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.